Cargando…

Efficacy and safety of Danlou tablets in traditional Chinese medicine for coronary heart disease: a systematic review and meta-analysis

BACKGROUND: Danlou tablets exert auxiliary advantages in treating coronary heart disease (CHD), but a summary of evidence-based proof is lacking. This study aims to systematically evaluate Danlou tablets in treating CHD from two aspects, including efficacy and safety. METHODS: By a thorough retrieva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, WeiLi, Lu, Peng, Wan, Renhong, Mao, Kaili, Lv, Yanzhu, Hu, Jie, Fu, Zhenling, Wang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282777/ https://www.ncbi.nlm.nih.gov/pubmed/37351285 http://dx.doi.org/10.3389/fcvm.2023.1100006

Ejemplares similares

PPARγ Mediates the Cardioprotective Roles of Danlou Tablet After Acute Myocardial Ischemia-Reperfusion Injury
por: Wei, Meng, et al.
Publicado: (2022)

Traditional Chinese medicine, Danlou tablets alleviate adverse left ventricular remodeling after myocardial infarction: results of a double-blind, randomized, placebo-controlled, pilot study
por: Mao, Shuai, et al.
Publicado: (2016)

Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial
por: Wang, Lei, et al.
Publicado: (2016)

Traditional Chinese medicine injections for heart failure: a protocol for systematic review and network meta-analysis of randomised controlled trials
por: Lin, Shanshan, et al.
Publicado: (2020)

Therapeutic Effects of Traditional Chinese Medicine for Patients With Coronary Heart Disease After Treatment of Revascularization: A Prospective Cohort Study in the Northern of China
por: Lv, Chunxiao, et al.
Publicado: (2021)

Danlou Tablet May Alleviate Vascular Injury Caused by Chronic Intermittent Hypoxia through Regulating FIH-1, HIF-1, and Angptl4
por: Rong, Yi, et al.
Publicado: (2022)

Danlou tablet inhibits high-glucose-induced cardiomyocyte apoptosis via the miR-34a-SIRT1 axis
por: Chen, Rui, et al.
Publicado: (2023)

Traditional Chinese Medicine for Coronary Artery Disease Treatment: Clinical Evidence From Randomized Controlled Trials
por: Liang, Bo, et al.
Publicado: (2021)

Effects of Danlou tablet for the treatment of stable angina pectoris: A study protocol of a randomized, double-blind, and placebo-controlled clinical trial
por: Yang, Guang, et al.
Publicado: (2020)

Traditional chinese medicine in coronary microvascular disease
por: Yang, Zhihua, et al.
Publicado: (2022)

Development of a core outcome set on Traditional Chinese Medicine and Western Medicine for rheumatic heart disease: a study protocol
por: Sheng, Xiaodi, et al.
Publicado: (2022)

Danlou Tablets Inhibit Atherosclerosis in Apolipoprotein E-Deficient Mice by Inducing Macrophage Autophagy: The Role of the PI3K-Akt-mTOR Pathway
por: Liu, Chunping, et al.
Publicado: (2021)

Role and molecular mechanism of traditional Chinese medicine in preventing cardiotoxicity associated with chemoradiotherapy
por: Lv, Xin-Fang, et al.
Publicado: (2022)

Cellular and Molecular Mechanism of Traditional Chinese Medicine on Ventricular Remodeling
por: Zhu, Yong-Chun, et al.
Publicado: (2021)

Danlou Tablet Activates Autophagy of Vascular Adventitial Fibroblasts Through PI3K/Akt/mTOR to Protect Cells From Damage Caused by Atherosclerosis
por: Wang, Li, et al.
Publicado: (2021)

Effects and Safety of Non-Pharmacological Therapies of Traditional Chinese Medicine for Coronary Heart Disease: An Overview of Systematic Reviews
por: Ji, Weiqiang, et al.
Publicado: (2022)

Traditional Chinese medicine method of tonifying kidney for hypertension: Clinical evidence and molecular mechanisms
por: Wang, Qingqing, et al.
Publicado: (2022)

Efficacy of Chinese traditional patent medicines for heart failure with preserved ejection fraction: a Bayesian network meta-analysis of 64 randomized controlled trials
por: Guo, Hongxin, et al.
Publicado: (2023)

Traditional Chinese Medicine for Coronary Heart Disease: Clinical Evidence and Possible Mechanisms
por: Zhang, Ke-Jian, et al.
Publicado: (2019)

The application and mechanism of Chinese medicine in the upstream treatment of atrial fibrillation
por: Liu, Min, et al.
Publicado: (2023)

Reliable Multi-Label Learning via Conformal Predictor and Random Forest for Syndrome Differentiation of Chronic Fatigue in Traditional Chinese Medicine
por: Wang, Huazhen, et al.
Publicado: (2014)

Integrated Chinese and Western medicine for stable angina pectoris of coronary heart disease: a real-world study including 690 patients
por: Yu, Linghua, et al.
Publicado: (2023)

Correlation Between Smoking Paradox and Heart Rhythm Outcomes in Patients With Coronary Artery Disease Receiving Percutaneous Coronary Intervention
por: Wu, Han-Ping, et al.
Publicado: (2022)

Plasma metabolomic analysis reveals the therapeutic effects of Jiashen tablets on heart failure
por: Miao, Xinglong, et al.
Publicado: (2022)

The Role of Traditional Chinese Medicine in the Regulation of Oxidative Stress in Treating Coronary Heart Disease
por: Yang, Xinyu, et al.
Publicado: (2019)

A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors
por: Mao, Weili, et al.
Publicado: (2022)

Association Between Social Support and Medication Literacy in Chinese Patients With Coronary Heart Disease
por: Qiao, Li, et al.
Publicado: (2021)

Perceived stress in Chinese patients with coronary heart disease: a cross-sectional study
por: Gao, Yifan, et al.
Publicado: (2022)

Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure
por: Chen, Lizhen, et al.
Publicado: (2022)

Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease
por: Cheng, Tian-Yi, et al.
Publicado: (2021)

Coronary heart disease and gut microbiota: A bibliometric and visual analysis from 2002 to 2022
por: Long, Dan, et al.
Publicado: (2022)

Digitalization of prevention and treatment and the combination of western and Chinese medicine in management of acute heart failure
por: Wang, Yingxin, et al.
Publicado: (2023)

Plasma fingerprint of free fatty acids and their correlations with the traditional cardiac biomarkers in patients with type 2 diabetes complicated by coronary heart disease
por: Hu, Ting, et al.
Publicado: (2022)

Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms
por: Fan, Yujian, et al.
Publicado: (2023)

Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity
por: Xu, Shasha, et al.
Publicado: (2018)

Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure
por: Wang, Anzhu, et al.
Publicado: (2022)

Safety Concerns of Traditional Chinese Medicine Injections Used in Chinese Children
por: Tan, Liping, et al.
Publicado: (2019)

Modelling of inquiry diagnosis for coronary heart disease in traditional Chinese medicine by using multi-label learning
por: Liu, Guo-Ping, et al.
Publicado: (2010)

Cost-effectiveness analysis of combining traditional Chinese medicine in the treatment of hypertension: compound Apocynum tablets combined with Nifedipine sustained-release tablets vs Nifedipine sustained-release tablets alone
por: Xu, Qian, et al.
Publicado: (2020)

Corrected QT Interval Is Associated With Stroke but Not Coronary Heart Disease: Insights From a General Chinese Population
por: Guo, Xiaofan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_epo3qesrd18iaj5lus5q5c6e6j